Pacira Biosciences
PCRX
#6006
Rank
โ‚ฌ0.87 B
Marketcap
20,35ย โ‚ฌ
Share price
2.32%
Change (1 day)
-15.14%
Change (1 year)
Categories

Pacira Biosciences (PCRX) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚ฌ1.08 Billion

According to Pacira Biosciences 's latest financial reports the company's total assets are โ‚ฌ1.08 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Pacira Biosciences - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ1.07 B-27.87%
2024-12-31โ‚ฌ1.49 B4.82%
2023-12-31โ‚ฌ1.42 B-9.13%
2022-12-31โ‚ฌ1.56 B-14.47%
2021-12-31โ‚ฌ1.83 B76.85%
2020-12-31โ‚ฌ1.03 B39.67%
2019-12-31โ‚ฌ0.74 B23.11%
2018-12-31โ‚ฌ0.60 B15.06%
2017-12-31โ‚ฌ0.52 B40.72%
2016-12-31โ‚ฌ0.37 B4.95%
2015-12-31โ‚ฌ0.35 B32.27%
2014-12-31โ‚ฌ0.26 B118.03%
2013-12-31โ‚ฌ0.12 B45.16%
2012-12-31โ‚ฌ84.71 M-3.07%
2011-12-31โ‚ฌ87.39 M74.63%
2010-12-31โ‚ฌ50.04 M63.11%
2009-12-31โ‚ฌ30.67 M-15.14%
2008-12-31โ‚ฌ36.15 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚ฌ0.15 B-85.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
โ‚ฌ0.21 B-80.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
โ‚ฌ37.49 M-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA